No quarterly revenue total was found in MOSAIC IMMUNOENGINEERING, INC.'s SEC filings.
Mosaic Immunoengineering, Inc. (CPMV) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income
$-177,496
-3.2% vs year-ago quarter
Operating cash flow
$-46
+99.9% vs year-ago quarter
Free cash flow
—
EPS
$-0.02
+0.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.24M
+0.0% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CPMV (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Huntington Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 836564
- Former names
- PATRIOT SCIENTIFIC CORP (until Nov 19, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$156,721 | -$154,802 | -$148,133 | -$144,358 | -$148,854 |
| Net income | -$177,496 | -$175,351 | -$169,137 | -$165,361 | -$172,028 |
| Diluted EPS | -$0.02 | -$0.02 | — | -$0.02 | -$0.02 |
| Operating cash flow | -$46 | -$3,550 | -$28,139 | -$21,822 | -$32,347 |
| Total assets | $3,278 | $9,828 | $19,882 | $55,298 | $57,699 |
| Total liabilities | $7.8M | $7.7M | $7.5M | $7.4M | $7.2M |
| Stockholders' equity | -$7.8M | -$7.7M | -$7.5M | -$7.3M | -$7.1M |
| Cash and investments | $26 | $72 | $3,622 | $31,761 | $53,583 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
All 553 Mosaic Immunoengineering, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.